
Mounjaro Approved for Sleep Apnea: A New Hope for Better Sleep
Recent approval of Mounjaro (tirzepatide) for obstructive sleep apnea (OSA) in obese individuals signifies a groundbreaking advancement. This development addresses a critical need, offering a novel pharmacological approach to a condition affecting millions.







